Press "Enter" to skip to content

New patent for Sebela Ireland drug NAFTIN

0
Copyright © DrugPatentWatch. Originally published at New patent for Sebela Ireland drug NAFTIN

Annual Drug Patent Expirations for NAFTIN
Annual Drug Patent Expirations for NAFTIN

Naftin is a drug marketed by Sebela Ireland Ltd and is included in three NDAs. It is available from three suppliers. There are two patents protecting this drug and one Paragraph IV challenge.

NAFTIN drug price trends.

Drug patent litigation for NAFTIN.

This drug has three patent family members in three countries.

The generic ingredient in NAFTIN is naftifine hydrochloride. Three suppliers are listed for this compound. Additional details are available on the naftifine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Sebela Ireland drug NAFTIN
    Do NOT follow this link or you will be banned from the site!